TY  - JOUR
AU  - Kharfan-Dabaja, M A
AU  - Parody, R
AU  - Perkins, J
AU  - Lopez-Godino, O
AU  - Lopez-Corral, L
AU  - Vazquez, L
AU  - Caballero, D
AU  - Falantes, J
AU  - Shapiro, J
AU  - Ortí, G
AU  - Barba, P
AU  - Valcárcel, D
AU  - Esquirol, A
AU  - Martino, R
AU  - Piñana, J L
AU  - Solano, C
AU  - Tsalatsanis, A
AU  - Pidala, J
AU  - Anasetti, C
AU  - Perez-Simón, J A
PY  - 2016
DO  - 10.1038/bmt.2016.269
UR  - http://hdl.handle.net/10668/10584
T2  - Bone marrow transplantation
AB  - HLA-matched related or unrelated donors are not universally available. Consequently, patients can be offered hematopoietic stem cell transplantation (HSCT) from alternative donors, including mismatched unrelated donors (MMURD), known to cause a higher...
LA  - en
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Allografts
KW  - Chronic Disease
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - HLA Antigens
KW  - Humans
KW  - Lymphocyte Depletion
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Sirolimus
KW  - Stem Cell Transplantation
KW  - Survival Rate
KW  - T-Lymphocytes
KW  - Tacrolimus
KW  - Unrelated Donors
TI  - Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
TY  - research article
VL  - 52
ER  -